To investigate whether increasing water intake has renal protective effect on PA patients after surgical treatment.
This is a single-center randomized controlled trial study to verify the effect of drinking water on renal function after PA surgery treatment and to follow up the clinical outcomes. We will take short-term follow-up on whether increasing water intake can improve eGFR decline in the early stage of PA patients after surgical treatment and further long-term follow-up to investigate whether increasing drinking water has long-term memory effect to slow down renal function deterioration and improve clinical outcomes. This study will be completed in 1 year.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
the same with arm descriptions
The First Affilated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Renal decline
Change in estimated glomerular filtration rate between baseline and 3 months
Time frame: Baseline and 3 months
24-hour urine albumin
Change in 24-hour urine albumin among baseline, 3 and 6 months
Time frame: Baseline,3 and 6 months
Rapid renal decline
Proportion with eGFR (estimated glomerular filtration rate) decline \>5% among Baseline 3, and 6 months
Time frame: Baseline 3, and 6 months
Measured creatinine clearance
Change in measured creatinine clearance among baseline, 3 and 6 months
Time frame: Baseline 3, and 6 months
Copeptin
Change in copeptin among baseline, 3 and 6 months
Time frame: Baseline 3, and 6 months
Blood pressure
Change in blood pressure among baseline, 3 and 6 months
Time frame: Baseline 3, and 6 months
Waist circumference
Change in waist circumference among baseline, 3 and 6 months
Time frame: Baseline 3, and 6 months
Body mass index
Change in body mass index among baseline, 3 and 6 months
Time frame: Baseline 3, and 6 months
Renal events
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Two of the three morning urine UACR\&\>300 mg/g Cr, or 24-hour urine protein \>300 mg/ 24 h, or serum creatinine level doubled and reached at least 200 μmol/l(2.26 mg/dl), or required renal replacement therapy, or died of renal diseases
Time frame: Baseline and 12 months